Topo Therapeutics

Cambridge, MA · Founded 2024 · Privately Held (backing)

Operator of small molecule therapeutics intended to accelerate transmembrane protein drug discovery. Topo Therapeutics is based in Cambridge, MA and was founded in 2024. It was valued at $138 million at its early-stage round in Dec 2024, the last priced event on record. It has raised $10.6 million across 1 recorded round; the latest was a $10.6 million early-stage round in Dec 2024.

PMV mark · valuation
$137.6M
Oct 2026
Priced at
its early-stage round
Dec 2024
Total raised
$10.6M
Last round
Early Stage VC
Dec 2024
What is Topo Therapeutics worth?
$137.6MPrivateMarketView mark · Oct 2026

Valued at $137.6M at its early-stage round, Dec 2024. Nothing has traded since.

Free account
More of Topo Therapeutics with a free account
  • ·Watch Topo Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Topo Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Dec 2024Early Stage VC$10.6M▮
Unlock post-money valuations

Membership and data by Private Market View

Topo Therapeutics valuation

Topo Therapeutics was valued at $138 million at its early-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Topo Therapeutics raised?

Topo Therapeutics has raised $10.6 million across 1 recorded round since 2024. The largest was a $10.6 million early-stage round in Dec 2024.

Topo Therapeutics has filed 2 Form Ds with the SEC, most recently in Dec 2024 ($10.6 million sold to 4 investors).

How Topo Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Topo Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Topo Therapeutics

What is Topo Therapeutics worth?
Topo Therapeutics is valued at $137.6M as of Oct 2026. Valued at $137.6M at its early-stage round, Dec 2024. Nothing has traded since.
How much has Topo Therapeutics raised?
Topo Therapeutics has raised $10.6M in total funding across 1 recorded rounds.
When did Topo Therapeutics last raise?
Topo Therapeutics last raised in Dec 2024 (Early Stage VC), raising $10.6M.